Stereoselective chromatography of cardiovascular drugs: an update.
This review reports the latest achievements in chromatographic enantioseparations of various classes of cardiovascular drugs and selected applications of these methods in pharmaceutical and clinical analysis. The use of these drugs as test compounds for new chiral stationary phases and different parameters of chromatographic processes is also presented.
Bojarski
Jacek
J
Department of Organic Chemistry, Medical College, Faculty of Pharmacy, Jagiellonian University, Medyczna 9, 30-688 Cracow, Poland. mfbojars@cyf-kr.edu.pl
D000319:Adrenergic beta-Antagonists / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification; D000889:Anti-Arrhythmia Agents / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification; D001993:Bronchodilator Agents / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification; D002121:Calcium Channel Blockers / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification; D002317:Cardiovascular Agents / Q000032:analysis* / Q000737:chemistry / Q000302:isolation & purification; D002845:Chromatography / Q000379:methods*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D010601:Pharmacology, Clinical / Q000379:methods*; D012680:Sensitivity and Specificity; D013237:Stereoisomerism
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001993:Bronchodilator Agents; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents